N/A
Completed N=20
Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients
Cancer-related Problem/Condition · Ambulatory Care
Source: ClinicalTrials.gov NCT01967836 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcomePrimary: Patient Subject Questionnaire Post Shower Evaluation — 80; 88; 76; 0 percentage of yes responses
Summary
The purpose of this study is to see if Glad Press 'n Seal works as a moisture barrier for central line that is left in place during ambulatory oncology clinical care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Subject Questionnaire Post Shower Evaluation |
80; 88; 76; 0 | — |
| PRIMARY Patient Satisfaction Mean on a 0-10 Likert Scale on the Use of Glad Press 'n Seal During Showering. 40 Subjects Reports. |
7.65 | — |
| SECONDARY Clinic Nurse Observation of Subjects, Who Used Intervention Device, at the Next Clinic Visit |
91; 93; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Subjects requiring mediport or peripherally inserted central venous catheter line access for 3-5 days
- Able to read and write English
- Use showering as a means of home hygiene
Exclusion Criteria
- Subjects with eczema/psoriasis at the line insertion area
- Subjects with active line/site irritation/infection
- Subjects on chemotherapy protocols including anti-epidermal growth factor receptor drugs (cetuximab, panitumumab) or ipilimumab as there is a high incidence of skin rash as a side effect of these medications
- Patients who do not intend to shower as a means of home hygiene
Data sourced from ClinicalTrials.gov (NCT01967836). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.